Literature DB >> 22643330

Reconstitution of 6-sulfo LacNAc dendritic cells after allogeneic stem-cell transplantation.

Konrad Mager1, Rebekka Wehner, Felix Bahr, Uta Oelschlägel, Uwe Platzbecker, Martin Wermke, Nona Shayegi, Jan Moritz Middeke, Jörgen Radke, Christoph Röllig, Johannes Schetelig, Christian Thiede, Gerhard Ehninger, Marc Schmitz, Martin Bornhäuser, Sebastian Tuve.   

Abstract

BACKGROUND: Infections and acute graft-versus-host disease (GvHD) represent major complications of allogeneic stem-cell transplantation (SCT). Dendritic cells (DCs) display an extraordinary capacity to induce innate and adaptive immune responses. Therefore, they play a crucial role in the elimination of pathogens and in the pathogenesis of acute GvHD. 6-Sulfo LacNAc DCs (slanDCs) are a major subpopulation of human blood DCs with a high proinflammatory capacity. We investigated for the first time the reconstitution of slanDCs in the blood of patients after SCT and the modulation of their frequency by bacterial infection, cytomegalovirus (CMV) reactivation, and acute GvHD.
METHODS: The frequency of slanDCs, CD1c myeloid DCs (mDCs), and plasmacytoid DCs (pDCs) in the peripheral blood was quantified by flow cytometry in 80 patients after SCT. To assess individual DC subsets, we used pregating of the HLADRLin subset and antibodies against slanDCs, blood DC antigen 1 (CD1c mDCs), and blood DC antigen 2 (pDCs).
RESULTS: SlanDCs showed the slowest reconstitution in the first month after SCT compared with CD1c mDCs and pDCs. Interestingly, in the second and third months after SCT, their percentage steadily increased, and slanDCs were the most abundant DC subset. In addition, we observed a markedly reduced frequency of slanDCs in the blood of patients with bacterial infection, CMV reactivation, or severe acute GvHD. Furthermore, slanDCs showed the most prominent reduction after steroid treatment of acute GvHD.
CONCLUSIONS: These results indicate that SCT-associated complications such as bacterial infection, CMV reactivation, and acute GvHD can significantly modulate the frequency of slanDCs.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22643330     DOI: 10.1097/TP.0b013e31824fd8b4

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  4 in total

1.  Rapid reconstitution of functionally active 6-sulfoLacNAc(+) dendritic cells (slanDCs) of donor origin following allogeneic haematopoietic stem cell transplant.

Authors:  E Mimiola; O Marini; O Perbellini; A Micheletti; W Vermi; S Lonardi; C Costantini; E Meneghelli; A Andreini; C Bonetto; A Vassanelli; M Cantini; E Zoratti; D Massi; A Zamo'; A Leso; G Quaresmini; F Benedetti; G Pizzolo; M A Cassatella; C Tecchio
Journal:  Clin Exp Immunol       Date:  2014-10       Impact factor: 4.330

2.  Proinflammatory human 6-sulfo LacNAc-positive dendritic cells accumulate in intestinal acute graft-versus-host disease.

Authors:  Ulrich Sommer; Brit Larsson; Sebastian Tuve; Rebekka Wehner; Nick Zimmermann; Michael Kramer; Anja Kloβ; Claudia Günther; Jana Babatz; Renate Schmelz; Stefan Brückner; Johannes Schetelig; Martin Bornhäuser; Knut Schäkel; Michael Philipp Bachmann; Daniela Aust; Gustavo Baretton; Marc Schmitz
Journal:  Haematologica       Date:  2014-03-28       Impact factor: 9.941

Review 3.  The role of dendritic cells in graft-versus-tumor effect.

Authors:  Tomomi Toubai; Nathan Mathewson; Pavan Reddy
Journal:  Front Immunol       Date:  2014-02-21       Impact factor: 7.561

Review 4.  Current Concepts on 6-sulfo LacNAc Expressing Monocytes (slanMo).

Authors:  Fareed Ahmad; Thomas Döbel; Marc Schmitz; Knut Schäkel
Journal:  Front Immunol       Date:  2019-05-22       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.